Improving Survivorship Care for Older Adults After Chemotherapy
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Survivorship
- Sponsor
- University of California, San Francisco
- Enrollment
- 70
- Locations
- 1
- Primary Endpoint
- Number of months needed for completion of trial enrollment
- Status
- Recruiting
- Last Updated
- 11 months ago
Overview
Brief Summary
The researchers want to find out if older adults receiving a survivorship care plan followed by a geriatric assessment visit improves quality of life and satisfaction with care compared to receiving only a survivorship care plan for older adults who have completed chemotherapy for cancer treatment.
Detailed Description
This study is a pilot randomized trial to examine whether a geriatric assessment-enhanced survivorship care plan improves satisfaction, knowledge and health-related quality of life compared to standard survivorship care plans among older adults who have completed curative chemotherapy for cancer. The investigator's hypothesis is that older adults who receive a geriatric assessment-enhanced survivorship care plan will report improved satisfaction with care, health-related quality of life, and knowledge and preparedness for survivorship care needs.
Investigators
Eligibility Criteria
Inclusion Criteria
- •age 65 years and above and
- •Have diagnosis of cancer and have completed chemotherapy with curative (not palliative) intent and
- •have been scheduled to receive a survivorship care plan from an oncology navigator.
Exclusion Criteria
- •advanced dementia or serious cognitive impairment that would impede ability to participate in the interview
- •nursing home resident.
Outcomes
Primary Outcomes
Number of months needed for completion of trial enrollment
Time Frame: 4-6 months
Acceptability of the study: survey
Time Frame: 4-6 months
Assess acceptability via a short survey administered to participating oncology nurse navigators and patients selected for the intervention group.
Study retention rate
Time Frame: 4-6 months
Feasibility of the study will be assessed by study retention rate which is defined as proportion of enrolled participants who remain enrolled until study completion.
Secondary Outcomes
- Patient satisfaction assessment by PSCC (Patient Satisfaction with Cancer related Care) tool(4-6 months)
- Health related quality of life assessment by QLQ14(4-6 months)
- Self rated patient knowledge and preparedness measured by PLANS assessment tool (Preparing for Life as a New Survivor)(4-6 months)
- Health related quality of life assessment by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire EORTC QLQ-30(4-6 months)